Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 456

1.

Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.

Kwong JC, Buchan SA, Chung H, Campitelli MA, Schwartz KL, Crowcroft NS, Jackson ML, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Simor A, Smieja M, Zahariadis G, Campigotto A, Gubbay JB.

Vaccine. 2019 Jun 17. pii: S0264-410X(19)30772-8. doi: 10.1016/j.vaccine.2019.06.011. [Epub ahead of print]

PMID:
31221563
2.

Which healthcare workers work with acute respiratory illness? Evidence from Canadian acute-care hospitals during 4 influenza seasons: 2010-2011 to 2013-2014.

Jiang L, McGeer A, McNeil S, Katz K, Loeb M, Muller MP, Simor A, Powis J, Kohler P, Di Bella JM, Coleman BL; Canadian Healthcare Worker Study Group.

Infect Control Hosp Epidemiol. 2019 Jun 18:1-8. doi: 10.1017/ice.2019.141. [Epub ahead of print]

PMID:
31208477
3.

The Urine Culturing Cascade: Variation in Nursing Home Urine Culturing and Association with Antibiotic Use and C. difficile infection.

Brown KA, Daneman N, Schwartz KL, Langford B, McGeer A, Quirk J, Diong C, Garber G.

Clin Infect Dis. 2019 Jun 14. pii: ciz482. doi: 10.1093/cid/ciz482. [Epub ahead of print]

PMID:
31197362
4.

The TransFLUas influenza transmission study in acute healthcare - recruitment rates and protocol adherence in healthcare workers and inpatients.

Schwarz H, Böni J, Kouyos RD, Turk T, Battegay E, Kohler M, Müller R, Petry H, Sax H, Weber R, McGeer A, Trkola A, Kuster SP.

BMC Infect Dis. 2019 May 21;19(1):446. doi: 10.1186/s12879-019-4057-5.

5.

Influenza virus RNA recovered from droplets and droplet nuclei emitted by adults in an acute care setting.

Yip L, Finn M, Granados A, Prost K, McGeer A, Gubbay JB, Scott J, Mubareka S.

J Occup Environ Hyg. 2019 May;16(5):341-348. doi: 10.1080/15459624.2019.1591626. Epub 2019 May 3.

PMID:
31050610
6.

Characteristics and Outcomes of Young Children Hospitalized With Laboratory-confirmed Influenza or Respiratory Syncytial Virus in Ontario, Canada, 2009-2014.

Buchan SA, Chung H, Karnauchow T, McNally JD, Campitelli MA, Gubbay JB, Katz K, McGeer AJ, Richardson DC, Richardson SE, Simor A, Smieja M, Zahariadis G, Tran D, Crowcroft NS, Rosella LC, Kwong JC.

Pediatr Infect Dis J. 2019 Apr;38(4):362-369. doi: 10.1097/INF.0000000000002164.

PMID:
30882725
7.

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT.

Clin Infect Dis. 2019 Mar 5;68(6):895-902. doi: 10.1093/cid/ciy874. No abstract available.

PMID:
30834445
8.

Multilocus Variable-Number Tandem-Repeat Analysis of Clostridioides difficile Clusters in Ribotype 027 Isolates and Lack of Association with Clinical Outcomes.

Garneau JR, Abou Chakra CN, Fortier LC, Labbé AC, Simor AE, Gold W, Muller M, McGeer A, Powis J, Katz K, Pépin J, Valiquette L.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01724-18. doi: 10.1128/JCM.01724-18. Print 2019 May.

PMID:
30760531
9.

Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital.

Sheth PM, Douchant K, Uyanwune Y, Larocque M, Anantharajah A, Borgundvaag E, Dales L, McCreight L, McNaught L, Moore C, Ragan K, McGeer A, Broukhanski G.

PLoS One. 2019 Feb 11;14(2):e0207138. doi: 10.1371/journal.pone.0207138. eCollection 2019.

10.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.

Mulpuru S, Li L, Ye L, Hatchette T, Andrew MK, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.

PMID:
30616737
11.

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT.

Clin Infect Dis. 2019 Mar 5;68(6):e1-e47. doi: 10.1093/cid/ciy866.

PMID:
30566567
12.

The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada.

Nichols MK, Andrew MK, Ye L, Hatchette TF, Ambrose A, Boivin G, Bowie W, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Clin Infect Dis. 2018 Dec 3. doi: 10.1093/cid/ciy1009. [Epub ahead of print]

PMID:
30508064
13.

Emerging antimicrobial resistance among Escherichia coli strains in bloodstream infections in Toronto, 2006-2016: a retrospective cohort study.

Mineau S, Kozak R, Kissoon M, Paterson A, Oppedisano A, Douri F, Gogan K, Willey BM, McGeer A, Poutanen SM.

CMAJ Open. 2018 Dec 3;6(4):E580-E586. doi: 10.9778/cmajo.20180039. Print 2018 Oct-Dec.

14.

Prevalence of antibiotic-resistant organisms in Canadian Hospitals. Comparison of point-prevalence survey results from 2010, 2012, and 2016.

Martin P, Abou Chakra CN, Williams V, Bush K, Dyck M, Hirji Z, Kiss A, Larios OE, McGeer A, Moore C, Weiss K, Simor AE; Infection Prevention and Control Canada.

Infect Control Hosp Epidemiol. 2019 Jan;40(1):53-59. doi: 10.1017/ice.2018.279. Epub 2018 Nov 5.

PMID:
30394232
15.

Exposure to rabies during pregnancy.

Windrim C, McGeer AJ, Murphy KE.

CMAJ. 2018 Oct 29;190(43):E1281-E1283. doi: 10.1503/cmaj.180727. No abstract available.

PMID:
30373741
16.

Hand hygiene opportunities on Canadian acute-care inpatient units: A multicenter observational study.

Nayyar D, Moore C, McCreight L, Garvida C, Xu E, Kiss A, Ricciuto DR, McGeer A, Leis JA.

Infect Control Hosp Epidemiol. 2018 Nov;39(11):1378-1380. doi: 10.1017/ice.2018.221. Epub 2018 Sep 25.

PMID:
30249307
17.

Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada.

Neemuchwala A, Teatero S, Liang L, Martin I, Demzcuk W, McGeer A, Fittipaldi N.

Emerg Infect Dis. 2018 Oct;24(10):1941-1942. doi: 10.3201/eid2410.171711.

18.

Comparison of qPCR versus culture for the detection and quantification of Clostridium difficile environmental contamination.

MacDougall LK, Broukhanski G, Simor A, Johnstone J, Mubareka S, McGeer A, Daneman N, Garber G, Brown KA.

PLoS One. 2018 Aug 30;13(8):e0201569. doi: 10.1371/journal.pone.0201569. eCollection 2018.

19.

Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada1.

Kohler PP, Melano RG, Patel SN, Shafinaz S, Faheem A, Coleman BL, Green K, Armstrong I, Almohri H, Borgia S, Borgundvaag E, Johnstone J, Katz K, Lam F, Muller MP, Powis J, Poutanen SM, Richardson D, Rebbapragada A, Sarabia A, Simor A, McGeer A; Toronto Invasive Bacterial Diseases Network (TIBDN).

Emerg Infect Dis. 2018 Sep;24(9):1674-1682. doi: 10.3201/eid2409.180164.

20.

Increased environmental sample area and recovery of Clostridium difficile spores from hospital surfaces by quantitative PCR and enrichment culture.

Brown KA, MacDougall LK, Valenta K, Simor A, Johnstone J, Mubareka S, Broukhanski G, Garber G, McGeer A, Daneman N.

Infect Control Hosp Epidemiol. 2018 Aug;39(8):917-923. doi: 10.1017/ice.2018.103.

PMID:
30091692
21.

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.

Demczuk WHB, Martin I, Desai S, Griffith A, Caron-Poulin L, Lefebvre B, McGeer A, Tyrrell GJ, Zhanel GG, Gubbay J, Hoang L, Levett PN, Van Caeseele P, Raafat Gad R, Haldane D, Zahariadis G, German G, Daley Bernier J, Strudwick L, Mulvey MR.

Vaccine. 2018 Jul 25;36(31):4701-4707. doi: 10.1016/j.vaccine.2018.06.018. Epub 2018 Jun 21.

PMID:
29937245
22.

Comparison of response rates on invitation mode of a web-based survey on influenza vaccine adverse events among healthcare workers: a pilot study.

Tai X, Smith AM, McGeer AJ, Dubé E, Holness DL, Katz K, McGillis Hall L, McNeil SA, Powis J, Coleman BL.

BMC Med Res Methodol. 2018 Jun 20;18(1):59. doi: 10.1186/s12874-018-0524-8.

23.

High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial.

Vardeny O, Udell JA, Joseph J, Farkouh ME, Hernandez AF, McGeer AJ, Talbot HK, Bhatt DL, Cannon CP, Goodman SG, Anand I, DeMets DL, Temte J, Wittes J, Nichol K, Yancy CW, Gaziano JM, Cooper LS, Kim K, Solomon SD.

Am Heart J. 2018 Aug;202:97-103. doi: 10.1016/j.ahj.2018.05.007. Epub 2018 May 23.

PMID:
29909156
24.

Nasal colonization with Streptococcus pneumoniae and Staphylococcus aureus among hospitalized patients with laboratory-confirmed influenza.

Campigotto A, Simor AE, McGeer A, Kiss A, Mubareka S.

Diagn Microbiol Infect Dis. 2018 Oct;92(2):133-135. doi: 10.1016/j.diagmicrobio.2018.05.007. Epub 2018 Jun 5.

PMID:
29884564
25.

Immunogenicity and reactogenicity of high- vs. standard-dose trivalent inactivated influenza vaccine in healthcare workers: a pilot randomized controlled trial.

Volling C, Coleman BL, Katz K, Simor AE, Muller M, Powis J, McElhaney J, McGeer A.

Clin Microbiol Infect. 2019 Feb;25(2):217-224. doi: 10.1016/j.cmi.2018.05.002. Epub 2018 May 18.

PMID:
29783025
26.

Canada-Wide Epidemic of emm74 Group A Streptococcus Invasive Disease.

Teatero S, McGeer A, Tyrrell GJ, Hoang L, Smadi H, Domingo MC, Levett PN, Finkelstein M, Dewar K, Plevneshi A, Athey TBT, Gubbay JB, Mulvey MR, Martin I, Demczuk W, Fittipaldi N.

Open Forum Infect Dis. 2018 Apr 20;5(5):ofy085. doi: 10.1093/ofid/ofy085. eCollection 2018 May.

27.

Contact among healthcare workers in the hospital setting: developing the evidence base for innovative approaches to infection control.

English KM, Langley JM, McGeer A, Hupert N, Tellier R, Henry B, Halperin SA, Johnston L, Pourbohloul B.

BMC Infect Dis. 2018 Apr 17;18(1):184. doi: 10.1186/s12879-018-3093-x.

28.

Impact of Neonatal Intensive Care Unit Admission on Bacterial Colonization of Donated Human Milk.

Elmekkawi A, O'Connor DL, Stone D, Yoon EW, Larocque M, McGeer A, Unger S.

J Hum Lact. 2018 May;34(2):350-354. doi: 10.1177/0890334417753941. Epub 2018 Mar 27.

PMID:
29584524
29.

Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.

Kohler P, Eshaghi A, Kim HC, Plevneshi A, Green K, Willey BM, McGeer A, Patel SN; Toronto Invasive Bacterial Diseases Network (TIBDN).

PLoS One. 2018 Mar 22;13(3):e0193926. doi: 10.1371/journal.pone.0193926. eCollection 2018.

30.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Lagacé-Wiens P, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Schuind A, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN).

Vaccine. 2018 Apr 12;36(16):2166-2175. doi: 10.1016/j.vaccine.2018.02.093. Epub 2018 Mar 13.

PMID:
29548608
31.

Use of Genome Sequencing to Define Institutional Influenza Outbreaks, Toronto, Ontario, Canada, 2014-15.

MacFadden DR, McGeer A, Athey T, Perusini S, Olsha R, Li A, Eshaghi A, Gubbay JB, Hanage WP.

Emerg Infect Dis. 2018 Mar;24(3):492-497. doi: 10.3201/eid2403.171499.

32.

Resistance patterns of Enterobacteriaceae in urines are similar in symptomatic and asymptomatic patients.

Romero Palacios A, Al Dhufairi F, Ellis C, Smyth D, Mieusement LMD, McGeer A, Mertz D.

J Hosp Infect. 2018 Aug;99(4):419-421. doi: 10.1016/j.jhin.2018.02.006. Epub 2018 Feb 10.

PMID:
29432819
33.

Factors associated with influenza vaccination among healthcare workers in acute care hospitals in Canada.

Hussain H, McGeer A, McNeil S, Katz K, Loeb M, Simor A, Powis J, Langley J, Muller M; Canadian Health Care Worker Study Group, Coleman BL.

Influenza Other Respir Viruses. 2018 May;12(3):319-325. doi: 10.1111/irv.12545. Epub 2018 Mar 2.

34.

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB.

N Engl J Med. 2018 Jan 25;378(4):345-353. doi: 10.1056/NEJMoa1702090.

35.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.

Andrew MK, Shinde V, Hatchette T, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Nichols MK, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN).

BMC Infect Dis. 2017 Dec 29;17(1):805. doi: 10.1186/s12879-017-2905-8.

36.

Case-control study of household contacts to examine immunological protection from Bordetella pertussis transmission - study protocol.

Bolotin S, Johnson C, Quach S, Ambrose A, DeCoutere S, Deeks SL, Drews S, Faheem A, Green K, Halperin SA, Hoang L, Jamieson F, Kollmann T, Marchand-Austin A, McCormack D, McGeer A, Murti M, Bba AO, Rebbapragada A, Vanderkooi OG, Wang J, Warshawsky B, Crowcroft NS; Canadian Immunization Research Network Provincial Collaborative Network.

CMAJ Open. 2017 Dec 19;5(4):E872-E877. doi: 10.9778/cmajo.20170072.

37.

Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.

Buchan SA, Chung H, Campitelli MA, Crowcroft NS, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson D, Richardson SE, Rosella LC, Simor A, Smieja M, Tran D, Zahariadis G, Kwong JC.

PLoS One. 2017 Nov 17;12(11):e0187834. doi: 10.1371/journal.pone.0187834. eCollection 2017.

38.

Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae.

Cheng MP, Bogoch II, Green K, Plevneshi A, Rudnick W, Shigayeva A, McGeer A, Lee TC; Toronto Invasive Bacterial Diseases Network .

Clin Infect Dis. 2018 Apr 3;66(8):1282-1285. doi: 10.1093/cid/cix999.

PMID:
29140429
39.

Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network.

Ng C, Ye L, Noorduyn SG, Hux M, Thommes E, Goeree R, Ambrose A, Andrew MK, Hatchette T, Boivin G, Bowie W, ElSherif M, Green K, Johnstone J, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Poirier A, Powis J, Richardson D, Sharma R, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN) Investigators; Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators.

Influenza Other Respir Viruses. 2018 Mar;12(2):232-240. doi: 10.1111/irv.12521. Epub 2018 Jan 24.

40.

Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study.

Luca DL, Kwong JC, Chu A, Sander B, O'Reilly R, McGeer AJ, Bloom DE.

Clin Infect Dis. 2018 Feb 1;66(4):541-547. doi: 10.1093/cid/cix850.

41.

Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis.

Kohler PP, Volling C, Green K, Uleryk EM, Shah PS, McGeer A.

Infect Control Hosp Epidemiol. 2017 Nov;38(11):1319-1328. doi: 10.1017/ice.2017.197. Epub 2017 Sep 27. Review.

PMID:
28950924
42.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.

Andrew MK, Shinde V, Ye L, Hatchette T, Haguinet F, Dos Santos G, McElhaney JE, Ambrose A, Boivin G, Bowie W, Chit A, ElSherif M, Green K, Halperin S, Ibarguchi B, Johnstone J, Katz K, Langley J, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McGeer A, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN).

J Infect Dis. 2017 Aug 15;216(4):405-414. doi: 10.1093/infdis/jix282.

43.

Genetic evidence for a novel variant of the pilus island 1 backbone protein in group B Streptococcus.

Teatero S, Neemuchwala A, Yang K, Gomes J, Athey TBT, Martin I, Demczuk W, McGeer A, Fittipaldi N.

J Med Microbiol. 2017 Oct;66(10):1409-1415. doi: 10.1099/jmm.0.000588. Epub 2017 Sep 19.

PMID:
28923133
44.

No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS).

Maxwell C, McGeer A, Tai KFY, Sermer M.

J Obstet Gynaecol Can. 2017 Aug;39(8):e130-e137. doi: 10.1016/j.jogc.2017.04.024.

PMID:
28729104
45.
46.

Measuring influenza RNA quantity after prolonged storage or multiple freeze/thaw cycles.

Granados A, Petrich A, McGeer A, Gubbay JB.

J Virol Methods. 2017 Sep;247:45-50. doi: 10.1016/j.jviromet.2017.05.018. Epub 2017 May 29.

PMID:
28572040
47.

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.

LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Li L, Ambrose A, Hatchette TF, Lang AL, Gillis H, Martin I, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy A, McGeer A, Moraca S, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Vaccine. 2017 Jun 22;35(29):3647-3654. doi: 10.1016/j.vaccine.2017.05.049. Epub 2017 May 26.

48.

Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing.

Demczuk WHB, Martin I, Hoang L, Van Caeseele P, Lefebvre B, Horsman G, Haldane D, Gubbay J, Ratnam S, German G, Daley Bernier J, Strudwick L, McGeer A, Zhanel GG, Van Domselaar G, Graham M, Mulvey MR.

PLoS One. 2017 May 22;12(5):e0178040. doi: 10.1371/journal.pone.0178040. eCollection 2017.

49.

High Incidence of Invasive Group A Streptococcal Infections in Remote Indigenous Communities in Northwestern Ontario, Canada.

Bocking N, Matsumoto CL, Loewen K, Teatero S, Marchand-Austin A, Gordon J, Fittipaldi N, McGeer A.

Open Forum Infect Dis. 2016 Dec 7;4(1):ofw243. doi: 10.1093/ofid/ofw243. eCollection 2017 Winter.

50.

Rapid Emergence of a New Clone Impacts the Population at Risk and Increases the Incidence of Type emm89 Group A Streptococcus Invasive Disease.

Teatero S, Coleman BL, Beres SB, Olsen RJ, Kandel C, Reynolds O, Athey TBT, Musser JM, McGeer A, Fittipaldi N.

Open Forum Infect Dis. 2017 Mar 4;4(2):ofx042. doi: 10.1093/ofid/ofx042. eCollection 2017 Spring.

Supplemental Content

Loading ...
Support Center